These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8056000)
1. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Schwartz PJ; Camm AJ; Frangin G; Janse MJ; Julian DG; Simon P Eur Heart J; 1994 May; 15(5):620-4. PubMed ID: 8056000 [No Abstract] [Full Text] [Related]
2. [Amiodarone and secondary prevention. The EMIAT study]. Munoz A Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998 [TBL] [Abstract][Full Text] [Related]
3. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197 [TBL] [Abstract][Full Text] [Related]
4. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial. Jafri SM; Borzak S; Goldberger J; Gheorghiade M Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860 [TBL] [Abstract][Full Text] [Related]
5. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies]. Kuck KH Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Boutitie F; Boissel JP; Connolly SJ; Camm AJ; Cairns JA; Julian DG; Gent M; Janse MJ; Dorian P; Frangin G Circulation; 1999 May; 99(17):2268-75. PubMed ID: 10226092 [TBL] [Abstract][Full Text] [Related]
7. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators. Camm AJ; Julian D; Janse G; Munoz A; Schwartz P; Simon P; Frangin G Am J Cardiol; 1993 Nov; 72(16):95F-98F. PubMed ID: 8237837 [TBL] [Abstract][Full Text] [Related]
8. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
9. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180 [TBL] [Abstract][Full Text] [Related]
10. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164 [TBL] [Abstract][Full Text] [Related]
14. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction. Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P; Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone and the heart. Ahmad S Tex Heart Inst J; 1995; 22(2):209. PubMed ID: 7647612 [No Abstract] [Full Text] [Related]
17. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Irvine J; Basinski A; Baker B; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P Psychosom Med; 1999; 61(6):729-37. PubMed ID: 10593621 [TBL] [Abstract][Full Text] [Related]
18. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG; Ridker PM JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557 [TBL] [Abstract][Full Text] [Related]
19. Amiodarone therapy in chronic heart failure and myocardial infarction: a review of the mortality trials with special attention to STAT-CHF and the GESICA trials. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina. Pinto JV; Ramani K; Neelagaru S; Kown M; Gheorghiade M Prog Cardiovasc Dis; 1997; 40(1):85-93. PubMed ID: 9247558 [TBL] [Abstract][Full Text] [Related]
20. Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial. Budaj A; Kokowicz P; Smielak-Korombel W; Kuch J; Krzemińska-Pakuøa M; Maciejewicz J; Nartowicz E; Zaleska T; Dyduszyński A; Ceremuzyński L Coron Artery Dis; 1996 Apr; 7(4):315-9. PubMed ID: 8853584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]